TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MIST

Milestone Pharmaceuticals Inc

Healthcare · Biotechnology

0.7884$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Milestone Pharmaceuticals Inc (MIST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.5% of the shares are freely tradable; institutional investors hold 41.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 41.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 85.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 14.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 125Mio.

Largest Shareholders

Institutions

Institutions MIST
Name Stake (%) Shares Change (%) Date
Propel Bio Management LLC 5.97 7,429,590 +80.4 06/30/2026
RTW INVESTMENTS, LLC 5.09 6,331,001 +152.6 03/31/2026
Simplify Asset Management Inc. 2.69 3,349,379 +122.3 06/30/2026
Millennium Management LLC 2.52 3,142,219 +103.5 06/30/2026
Two Sigma Investments LLC 1.64 2,040,015 -12.0 06/30/2026
The Goldman Sachs Group Inc 1.61 2,000,025 +0.0 03/31/2026
Marshall Wace Asset Management Ltd 1.56 1,944,530 +17.4 03/31/2026
Point72 Asset Management, L.P. 0.87 1,085,683 +125.1 03/31/2026
Balyasny Asset Management LLC 0.68 851,325 +0.0 03/31/2026

Funds

Funds MIST
Name Stake (%) Shares Change (%) Date
Simplify Propel Opportunities ETF 2.69 3,349,379 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?